| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
activin A receptor like type 1 | 0.570 | 0.621 | 8.2E-04 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
adaptor related protein complex 1 subunit mu 2 | 0.928 | 0.103 | 8.6E-08 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
amyotrophic lateral sclerosis 2 chromosome region 12 | 0.785 | 0.207 | 1.7E-22 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
apolipoprotein B receptor | 0.834 | 0.172 | 4.3E-07 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
apolipoprotein C3 | 0.552 | 0.586 | 9.4E-03 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
AT-rich interaction domain 5B | 0.672 | 0.345 | 1.00 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
ataxin 2 | 0.534 | 0.621 | 0.94 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
ATP binding cassette subfamily C member 4 | 0.565 | 0.690 | 7.9E-08 |
|
phenotype | 0.100 | 1 | 2 | 2017 | 2017 | ||||||||||
|
BCL2 antagonist/killer 1 | 0.588 | 0.586 | 6.6E-06 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
BCL2 like 1 | 0.471 | 0.828 | 0.94 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
BCL2, apoptosis regulator | 0.312 | 0.862 | 0.57 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
BRCA1 associated protein | 0.685 | 0.517 | 1.1E-04 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
cancer susceptibility 15 | 0.735 | 0.276 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | |||||||||||
|
capping actin protein of muscle Z-line subunit beta | 0.773 | 0.241 | 0.93 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
capping protein regulator and myosin 1 linker 1 | 0.785 | 0.241 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | |||||||||||
|
Cas scaffold protein family member 4 | 0.815 | 0.172 | 0.30 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
Cbl proto-oncogene | 0.550 | 0.586 | 4.5E-03 |
|
phenotype | 0.100 | 1 | 2 | 2017 | 2017 | ||||||||||
|
CD226 molecule | 0.630 | 0.483 | 4.4E-02 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
CD33 molecule | 0.567 | 0.586 | 6.3E-07 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
Cdk5 and Abl enzyme substrate 1 | 0.696 | 0.276 | 3.8E-03 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
checkpoint kinase 2 | 0.494 | 0.621 | 1.2E-23 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
chordin | 0.752 | 0.345 | 9.0E-05 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
cut like homeobox 1 | 0.520 | 0.655 | 1.00 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
cyclin dependent kinase inhibitor 2A | 0.321 | 0.828 | 0.38 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 | ||||||||||
|
cytosolic thiouridylase subunit 2 | 0.928 | 0.069 | 3.6E-21 |
|
phenotype | 0.100 | 1 | 1 | 2017 | 2017 |